Latest Microarrays Stories
SAN ANTONIO, Dec. 8, 2011 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced the presentation of the first-of-its-kind clinical outcomes study for biomarker discovery applying next generation sequencing (NGS) for whole transcriptome profiling of archival formalin-fixed paraffin embedded (FFPE) tumor specimens. Results presented at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium demonstrate that a proprietary RNA-Seq method developed at the company is...
Gene expression study made easy: Just sequence all of it In a new study, researchers have gained new insights into neural disease genes by sequencing virtually all the gene expression in the mouse neural retina. The technology to obtain such a “transcriptome” has become accessible enough that full-scale sequencing is the preferred method for asking genetics questions. The population of Eric Morrow’s seminar “Neurogenetics and Disease” comprises mainly undergraduates who were...
IRVINE, Calif. and AMSTERDAM, Dec. 6, 2011 /PRNewswire/ -- Agendia, an innovative molecular diagnostics company, today announced the introduction of formalin fixed, paraffin embedded tissue technology applied to their Symphony(TM) suite of breast cancer assays. Delivering Agendia's tests in a paraffin embedded tissue format offers their customers added convenience along with the superior science, development and validation found in Agendia's breast cancer Symphony suite....
SAN DIEGO, Dec. 6, 2011 /PRNewswire/ -- BioSurplus announced today that it will be hosting two major online lab equipment auctions beginning on January 5th and 26th, consecutively. The auctions feature high-quality used equipment from working labs, including Agilent 1100 HPLCs, a Micromass ZQ Mass spec with a Waters 2795 HPLC system, a Tecan Freedom Evo liquid handler, a Nikon TE 300 Inverted Research Microscope and many more. The January 5th auction includes a variety of...
HAMBURG, Germany, December 2, 2011 /PRNewswire/ -- Cross reference: Picture is available via epa european pressphoto agency and can be downloaded free of charge at: http://www.presseportal.de/pm/18701/eppendorf-ag?keygroup=bild In a well-received report in Science from 2008, Dr. Andrew Holt and his group from the University of Alberta, Canada, described how chemicals used as manufacturing additives can substantially inhibit enzymatic assays and binding studies by...
InDevR, a Boulder-based biotechnology company that develops advanced life science instrumentation and assays for analysis of viruses and other microorganisms, announced today the launch revolutionary new technology for microbiological analysis. ampliPHOX, a colorimetric detection system that incorporates core technology licensed from the University of Colorado Technology Transfer Office, will enhance laboratories around the world by offering a cost effective and easy to use alternative to...
HAMBURG, Germany, November 15, 2011 /PRNewswire/ -- Eppendorf AG has licensed patents covering gradient technology for thermal cyclers to Takara Bio, including US patent Nos. 6,767,512 and 7,074,367. Eppendorf utilizes the technology in its Eppendorf Mastercycler(R) pro gradient, Mastercycler gradient and Mastercycler ep realplex models. Eppendorf AG, based in Hamburg, Germany, develops, produces and distributes instruments and consumables for the Life Science research...
HAMBURG, Germany, November 3, 2011 /PRNewswire/ -- The Hamburg Life Science Specialist Opts For The Specialized PIM/MDM Platform From Stibo Systems Stibo Systems [http://www.stibosystems.com ], the Strategic Information Management Technology and Solutions CompanyTM today announced that Eppendorf AG based in Hamburg, has opted for the STEP platform in order to control all strategic product information about its 5,000 products centrally. Employees from around the world...
SAN DIEGO and TARRYTOWN, N.Y., Nov. 2, 2011 /PRNewswire/ -- Siemens Healthcare Diagnostics (NYSE: SI) and Illumina have entered into a partnership aimed at setting new standards in the use of next-generation sequencing for the rapid, accurate identification of patients' infectious disease states and potential treatment paths. Through this agreement, the companies plan to make existing Siemens molecular HIV tests compatible with the recently launched Illumina MiSeq(TM) next-generation...
Specific Research Interests are the Focus of New Discovery Tool Huntsville, AL (PRWEB) October 19, 2011 Microarrays Inc (MI) launches its new MI PathArray assays for studying targeted biological pathways. These pathway-centric arrays provide the highest microarray sensitivity in the form of more sharply focused research-specialty arrays, in a multi-assay format. The MI PathArray assays bring a fresh research tool to laboratories involved in the exploration of biological pathways. MI...
